首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1468359

按類型（戈謝氏症1 型、戈謝氏症2 型、戈謝氏症3 型等）、診斷和治療（診斷、治療）、最終用戶（醫院、專科診所、家庭護理等）和地區分類的戈謝病市場2024-2032

Gaucher Disease Market by Type (Gaucher Disease Type 1, Gaucher Disease Type 2, Gaucher Disease Type 3, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Specialty Clinics, Homecare, and Others), and Region 2024-2032

出版日期: 2024年04月08日 | 出版商:

IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

IMARC Group年，全球戈謝氏症市場規模達17億美元。越來越多的戈謝氏症患者、廣泛的研發（R＆D）活動以及藥物的容易取得是推動市場發展的一些關鍵因素。

戈謝氏症，也稱為溶小體儲存障礙，是一種罕見的遺傳代謝紊亂，影響身體分解和儲存脂肪的能力。它是由葡萄糖腦苷脂酶缺乏引起的，該酶會分解體內的葡萄糖腦苷脂脂肪化學物質。它與脾臟和肝臟腫大、貧血、容易瘀傷和出血、肺部問題、疲勞、癲癇發作和骨骼異常有關。它是透過各種身體檢查、病史和實驗室測試（例如血液和影像學測試）以及基因測試來確診，以確認基因中是否存在突變。戈謝氏症可以透過藥物、注射、酵素替代療法 (ERT)、骨髓移植和底物減少療法 (SRT) 來治療，有助於最大限度地減少與症狀相關的疼痛並提高生活品質。

戈謝氏症市場趨勢：

目前，個體遺傳異常盛行率的增加和戈謝氏症患者數量的增加是推動全球市場成長的主要因素之一。此外，日益成長的老化人口更容易患上這些疾病，導致對戈謝氏症治療的需求增加。此外，為戈謝氏症治療提供經濟資助、減少醫療費用的健康保險政策的實施也有所增加。除此之外，人們對戈謝氏症、其症狀、診斷以及治療方案的便利性的認知不斷增強，正在對市場產生積極影響。此外，許多國家的政府正在投資研發 (R&D) 活動，以研究戈謝氏症並開發新的治療方法。他們也採取措施向所有人提供優質的醫療設施。再加上診斷技術的顯著改進，正在為市場創造積極的前景。除此之外，人們越來越認知到 ERT 治療替代方案（例如有助於分解葡萄糖腦苷脂並減少累積的口服療法）的便利性，也促進了市場的成長。它們通常涉及非處方藥 (OTC) 和處方藥，用於緩解與戈謝氏症相關的疼痛。

本報告回答的關鍵問題

全球戈謝病市場有多大？
2024-2032年全球戈謝氏症市場的預期成長率是多少？
推動全球戈謝氏症市場的關鍵因素是什麼？
COVID-19 對全球戈謝氏症市場有何影響？
根據類型，全球戈謝氏症市場的詳細情形如何？
全球戈謝氏症市場的關鍵地區有哪些？
全球戈謝氏症市場的主要參與者/公司有哪些？

The global Gaucher disease market size reached US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.9 Billion by 2032, exhibiting a growth rate (CAGR) of 6.2% during 2024-2032. Increasing number of patients suffering from Gaucher disease, extensive research and development (R&D) activities, and the easy availability of drugs represent some of the key factors driving the market.

Gaucher disease, also known as lysosomal storage disorder, is a rare genetic metabolic disorder that affects the ability of the body to break down and store fats. It is caused by glucocerebrosidase deficiency, which breaks down glucocerebroside fatty chemicals in the body. It is associated with an enlarged spleen and liver, anemia, easy bruising and bleeding, lung problems, fatigue, seizures, and bone abnormalities. It is diagnosed through various physical examinations, medical history, and laboratory tests, such as blood and imaging tests, and genetic testing to confirm the presence of a mutation in the gene. Gaucher disease can be treated using medications, injections, enzyme replacement therapy (ERT), bone marrow transplantation, and substrate reduction therapy (SRT), which aid in minimizing the pain associated with the symptoms and improve the quality of life.

Gaucher Disease Market Trends:

At present, the increasing prevalence of genetic abnormalities among individuals and the rising number of patients suffering from Gaucher disease represent one of the major factors bolstering the market growth around the world. Moreover, the growing aging population that is more prone to developing these medical disorders is resulting in an increasing demand for Gaucher disease treatment. In addition, there is a rise in the implementation of health insurance policies that provide financial assistance for Gaucher disease treatment and reduce medical expenses. Apart from this, the growing awareness about Gaucher disease, its symptoms, diagnosis, and the easy availability of the treatment options is influencing the market positively. Furthermore, governments of numerous countries are investing in research and development (R&D) activities to study Gaucher disease and develop new treatments. They are also undertaking measures to offer quality healthcare facilities that are accessible to all. This, coupled with significant improvements in the diagnostic technologies, is creating a positive outlook for the market. Besides this, the rising awareness about the easy availability of ERT treatment alternatives like oral therapies that help break down glucocerebroside and reduce the accumulation is contributing to the growth of the market. They generally involve generic drugs that are readily available over the counter (OTC) and by prescription for relieving pain associated with Gaucher disease.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global Gaucher disease market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on type, diagnosis and treatment, and end user.

Type Insights:

Gaucher Disease Type 1

Gaucher Disease Type 2

Gaucher Disease Type 3

Others

The report has provided a detailed breakup and analysis of the Gaucher disease market based on the type. This includes Gaucher disease type 1, Gaucher disease type 2, Gaucher disease type 3, and others. According to the report, Gaucher disease type 1 represented the largest segment.

Diagnosis and Treatment Insights:

Diagnosis

Physical Exam

Blood Tests

Imaging Tests

Preconception Screening and Prenatal Testing

Others

Treatment

Surgery

Medication

Others

A detailed breakup and analysis of the Gaucher disease market based on the diagnosis and treatment has also been provided in the report. This includes diagnosis (physical exam, blood tests, imaging tests, preconception screening and prenatal testing, and others) and treatment (surgery, medication, and others).

End User Insights:

Hospitals

Specialty Clinics

Homecare

Others

The report has provided a detailed breakup and analysis of the Gaucher disease market based on the end user. This includes hospitals, specialty clinics, homecare, and others.

Regional Insights:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America was the largest market for Gaucher disease. Some of the factors driving the North America Gaucher disease market included increasing prevalence of genetic abnormalities, the presence of a well-established healthcare infrastructure, the integration of advanced medical technologies, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global Gaucher disease market. Detailed profiles of all major companies have also been provided. Some of the companies covered include ISU Abxis Co. Ltd., Johnson & Johnson, Pfizer Inc., Protalix Biotherapeutics, Sanofi S.A, Takeda Pharmaceutical Company Limited, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

1. How big is the global Gaucher disease market?
2. What is the expected growth rate of the global Gaucher disease market during 2024-2032?
3. What are the key factors driving the global Gaucher disease market?
4. What has been the impact of COVID-19 on the global Gaucher disease market?
5. What is the breakup of the global Gaucher disease market based on the type?
6. What are the key regions in the global Gaucher disease market?
7. Who are the key players/companies in the global Gaucher disease market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Gaucher Disease Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Gaucher Disease Type 1
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Gaucher Disease Type 2
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Gaucher Disease Type 3
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Others
- 6.4.1 Market Trends
- 6.4.2 Market Forecast

7 Market Breakup by Diagnosis and Treatment

7.1 Diagnosis
- 7.1.1 Market Trends
- 7.1.2 Key Segments
  - 7.1.2.1 Physical Exam
  - 7.1.2.2 Blood Tests
  - 7.1.2.3 Imaging Tests
  - 7.1.2.4 Preconception Screening and Prenatal Testing
  - 7.1.2.5 Others
- 7.1.3 Market Forecast
7.2 Treatment
- 7.2.1 Market Trends
- 7.2.2 Key Segments
  - 7.2.2.1 Surgery
  - 7.2.2.2 Medication
  - 7.2.2.3 Others
- 7.2.3 Market Forecast

8 Market Breakup by End User

8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Specialty Clinics
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Homecare
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

10.1 Overview
10.2 Drivers
10.3 Restraints
10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 ISU Abxis Co. Ltd.
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
- 14.3.2 Johnson & Johnson
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 Financials
  - 14.3.2.4 SWOT Analysis
- 14.3.3 Pfizer Inc.
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
  - 14.3.3.4 SWOT Analysis
- 14.3.4 Protalix Biotherapeutics
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 Financials
- 14.3.5 Sanofi S.A
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
  - 14.3.5.4 SWOT Analysis
- 14.3.6 Takeda Pharmaceutical Company Limited
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
  - 14.3.6.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

簡介目錄圖表

List of Figures

Figure 1: Global: Gaucher Disease Market: Major Drivers and Challenges
Figure 2: Global: Gaucher Disease Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Gaucher Disease Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Gaucher Disease Market: Breakup by Type (in %), 2023
Figure 5: Global: Gaucher Disease Market: Breakup by Diagnosis and Treatment (in %), 2023
Figure 6: Global: Gaucher Disease Market: Breakup by End User (in %), 2023
Figure 7: Global: Gaucher Disease Market: Breakup by Region (in %), 2023
Figure 8: Global: Gaucher Disease (Gaucher Disease Type 1) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Gaucher Disease (Gaucher Disease Type 1) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Gaucher Disease (Gaucher Disease Type 2) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Gaucher Disease (Gaucher Disease Type 2) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Gaucher Disease (Gaucher Disease Type 3) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Gaucher Disease (Gaucher Disease Type 3) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Gaucher Disease (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Gaucher Disease (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Gaucher Disease (Diagnosis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Gaucher Disease (Diagnosis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Gaucher Disease (Treatment) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Gaucher Disease (Treatment) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Gaucher Disease (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Gaucher Disease (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Gaucher Disease (Specialty Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Gaucher Disease (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Gaucher Disease (Homecare) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Gaucher Disease (Homecare) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Gaucher Disease (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Gaucher Disease (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: North America: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: North America: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: United States: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: United States: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Canada: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Canada: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Asia-Pacific: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Asia-Pacific: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: China: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: China: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Japan: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Japan: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: India: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: India: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: South Korea: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: South Korea: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Australia: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Australia: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Indonesia: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Indonesia: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Others: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Others: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Europe: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Europe: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Germany: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Germany: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: France: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: France: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: United Kingdom: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: United Kingdom: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Italy: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Italy: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Spain: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Spain: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Russia: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Russia: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Others: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Others: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Latin America: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Latin America: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Brazil: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Brazil: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Mexico: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Mexico: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Others: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Others: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Middle East and Africa: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Middle East and Africa: Gaucher Disease Market: Breakup by Country (in %), 2023
Figure 76: Middle East and Africa: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Global: Gaucher Disease Industry: Drivers, Restraints, and Opportunities
Figure 78: Global: Gaucher Disease Industry: Value Chain Analysis
Figure 79: Global: Gaucher Disease Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Gaucher Disease Market: Key Industry Highlights, 2023 & 2032
Table 2: Global: Gaucher Disease Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 3: Global: Gaucher Disease Market Forecast: Breakup by Diagnosis and Treatment (in Million US$), 2024-2032
Table 4: Global: Gaucher Disease Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 5: Global: Gaucher Disease Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Gaucher Disease Market: Competitive Structure
Table 7: Global: Gaucher Disease Market: Key Players

02-2729-4219

+886-2-2729-4219